NRC Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$26.00median target· current $19.51 (+33.3%)1 analyst
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio81.29Forward 17.21
EPS (TTM)$0.24-44.0% YoY
Profit margin4.2%HEALTHCARE
Market cap$431.9MSmall cap
Valuation
- Forward P/E
- 17.21
- PEG ratio
- 1.32
- P/B
- 65.94
- P/S (TTM)
- 3.08
- EV/EBITDA
- 22.14
Profitability & growth
- ROE (TTM)
- 42.0%
- Operating margin
- -9.2%
- Revenue growth YoY
- 4.0%
- Dividend yield
- 3.2%
- Beta
- 0.38
Last earnings
Jul 28, 2026 · Estimate $0.14 · Reported $0.31
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About National Research Corp
Company profileNational Research Corporation provides analytics and information that make it easy to measure and improve the patient and employee experience in the United States and Canada. The company is headquartered in Lincoln, Nebraska.
Classification
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 1245 Q STREET, LINCOLN, NE
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Market cap$431.9M
Shares outstanding$22.1M
52W high$23.68
52W low$10.74
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent